Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patientsCHANG, Jenny C; MAKRIS, Andreas; SEXTON, Krsytal et al.Breast cancer research and treatment. 2008, Vol 108, Num 2, pp 233-240, issn 0167-6806, 8 p.Article

Neoadjuvant trastuzumab induces apoptosis in primary breast cancersMOHSIN, Syed K; WEISS, Heidi L; ELLEDGE, Richard et al.Journal of clinical oncology. 2005, Vol 23, Num 11, pp 2460-2468, issn 0732-183X, 9 p.Article

Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K InhibitorsCHAKRABARTY, Anindita; BHOLA, Neil E; SUTTON, Cammie et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 3, pp 1190-1200, issn 0008-5472, 11 p.Article

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsCHANG, Jenny C; WOOTEN, Eric C; CHAMNESS, Gary C et al.Journal of clinical oncology. 2005, Vol 23, Num 6, pp 1169-1177, issn 0732-183X, 9 p.Article

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancersTHAM, Yee-Lu; GOMEZ, L. Fernando; CHANG, Jenny C et al.Breast cancer research and treatment. 2005, Vol 94, Num 3, pp 279-284, issn 0167-6806, 6 p.Article

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2―Overexpressing Breast Cancer: TBCRC 006RIMAWI, Mothaffar F; MAYER, Ingrid A; SCHIFF, Rachel et al.Journal of clinical oncology. 2013, Vol 31, Num 14, pp 1726-1731, issn 0732-183X, 6 p.Article

Microenvironmental Regulation of Epithelial―Mesenchymal Transitions in CancerDINGCHENG GAO; VAHDAT, Linda T; WONG, Stephen et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 19, pp 4883-4889, issn 0008-5472, 7 p.Article

ABT-869, a multitargeted receptor tyrosine kinase inhibitor : inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaSHANKAR, Deepa B; JUNLING LI; JUN GUO et al.Blood. 2007, Vol 109, Num 8, pp 3400-3408, issn 0006-4971, 9 p.Article

Development of Acneiform Rash Does Not Predict Response to Lapatinib Treatment in Patients with Breast CancerPARMA, Jennifer; PAVLICK, Anne; SCHIFF, Rachel et al.Pharmacotherapy. 2013, Vol 33, Num 10, pp 1126-1129, issn 0277-0008, 4 p.Article

A gene transcription signature of obesity in breast cancerCREIGHTON, Chad J; SADA, Yvonne H; YIQUN ZHANG et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 993-1000, issn 0167-6806, 8 p.Article

Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast densityWEI TSE YANG; LEWIS, Michael T; ARUN, Banu et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 305-314, issn 0167-6806, 10 p.Article

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast CancerCREIGHTON, Chad J; CHANG, Jenny C; ROSEN, Jeffrey M et al.Journal of mammary gland biology and neoplasia. 2010, Vol 15, Num 2, pp 253-260, issn 1083-3021, 8 p.Article

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsXIAOMEI ZHANG; CLAERHOUT, Sofie; HELEN WONG et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 15, pp 4885-4897, issn 0008-5472, 13 p.Article

High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR TherapyLITZENBURGER, Beate C; CREIGHTON, Chad J; LEWIS, Michael T et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2314-2327, issn 1078-0432, 14 p.Article

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistanceCLEATOR, Susan; TSIMELZON, Anna; CHANG, Jenny C et al.Breast cancer research and treatment. 2006, Vol 95, Num 3, pp 229-233, issn 0167-6806, 5 p.Article

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. CommentaryCHANG, Jenny C; WOOTEN, Eric C; O'CONNELL, Peter et al.Lancet (British edition). 2003, Vol 362, Num 9381, pp 340-341, issn 0140-6736, 10 p.Article

Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast CancerYU, Ke-Da; RUI ZHU; PIETENPOL, Jennifer A et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2723-2733, issn 1078-0432, 11 p.Article

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2-Overexpressing Locally Advanced Breast CancersDAVE, Bhuvanesh; MIGLIACCIO, Ilenia; RIMAWI, Mothaffar et al.Journal of clinical oncology. 2011, Vol 29, Num 2, pp 166-173, issn 0732-183X, 8 p.Article

Enhanced Mammary Progesterone Receptor-A Isoform Activity in the Promotion of Mammary Tumor Progression by Dietary Soy in RatsDAVE, Bhuvanesh; WYNNE, Rebecca; YING SU et al.Nutrition and cancer. 2010, Vol 62, Num 6, pp 774-782, issn 0163-5581, 9 p.Article

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to ChemotherapyXIAOXIAN LI; LEWIS, Michael T; WONG, Helen et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 9, pp 672-679, issn 0027-8874, 8 p.Article

Molecular heterogeneity of inflammatory breast cancer : A hyperproliferative phenotypeNGUYEN, Dang M; SAM, Kathy; O'CONNELL, Peter et al.Clinical cancer research. 2006, Vol 12, Num 17, pp 5047-5054, issn 1078-0432, 8 p.Article

Genomic approaches to understanding and treating breast cancerFUQUA, Suzanne A. W; CHANG, Jenny C; HILSENBECK, Susan G et al.Breast disease. 2004, Vol 19, pp 35-46, issn 0888-6008, 12 p.Article